Rubicon Organics Stock Price, News & Analysis

Rubicon Organics (ROMJF) reported strong financial results for 2024, with record-high net revenue of $48.7 million, representing a 21% increase from 2023. The company achieved an Adjusted EBITDA of $4.0 million and operating cash flow of $3.4 million.

Q4 2024 highlights include net revenue of $14.2 million (up 42% from Q4 2023), Adjusted EBITDA of $1.6 million, and positive operating cashflows of $2.3 million. The company secured $10 million in credit facilities at 6.75% interest for 5 years and entered into a purchase agreement for a Hope, BC facility that will expand premium flower capacity by 40%.

Key market positions include: 27.1% market share in topicals, 2.0% in national flower and pre-rolls, and 26.5% in premium edibles. The company's vape launch achieved 13.4% national market share with 56% distribution within six months.

Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF), a licensed producer specializing in organic certified and premium cannabis products, has announced its upcoming financial results release schedule. The company will report its Q4 2024 and full-year results for the period ended December 31, 2024, after market close on Tuesday, April 1, 2025. A conference call to discuss the results is scheduled for Wednesday, April 2, 2025.

Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) has achieved a significant milestone with its first international shipment of premium dried flower to Poland. The company, known for organic certified premium cannabis products, is expanding its reach into the European market, specifically Poland, which has over 90,000 medical cannabis patients.

The company is strengthening its production capabilities through a planned acquisition of a facility in Hope, BC, which will add 4,500 kgs of annual production capacity. This expansion aims to meet both international market demands and unfilled needs in the Canadian market.

Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF), Canada's leading premium cannabis producer, announces participation in two major industry events in March 2025.

The company will present at the Ventum Canadian Cannabis Conference on March 12th, where CEO Margaret Brodie will discuss financial performance and expansion plans during a 20-minute presentation at 2:40 PM EST. Rubicon was selected among top-performing companies showing profitable growth despite market challenges.

Additionally, Rubicon will attend the Global Cannabis Regulatory Summit in Washington, D.C. from March 25-27th. Hosted by Artemis Growth Partners at the U.S. Capitol Complex, this summit will unite international regulators, policymakers, and industry leaders from over a dozen countries to shape global cannabis policies and foster international partnerships.

Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) has announced plans to acquire a 47,500 square foot indoor cultivation facility in Hope, British Columbia from Medipharm Labs Inc. The purchase agreement is valued at $4.5 million and is subject to due diligence, financing, and board approval.

The acquisition of the Hope Facility represents a strategic move to expand the company's premium production capacity. The purpose-built facility will be used to increase production capabilities and meet growing demand for Rubicon's leading brand portfolio. The transaction is expected to close in the second quarter of 2025.

Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) has achieved a significant milestone by receiving the CUMCS Equivalency IMC-G.A.P. certification for its Delta Facility. This certification, granted by Control Union (CU), enables the company to export cannabis products to Israel, Europe, and Australia.

The certification confirms compliance with multiple international standards, including WHO guidelines on Good Agricultural Practices, European Medicines Agency's guidelines, Dutch Office of Medicinal Cannabis' Guidelines, and GLOBALG.A.P.'s IFA 4.0. This certification validates Rubicon's ability to meet strict international standards for quality and consistency in cannabis cultivation, harvest, and primary processing.

The company plans to initiate exports in 2025, targeting facilities with Good Manufacturing Practices (GMP) certification in these regions. CEO Margaret Brodie noted strong demand for Rubicon's premium and organic cannabis in international medical markets.

Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF), a licensed producer of organic certified and premium cannabis, has announced significant equity incentive grants. The company has awarded 784,712 restricted share units (RSUs) and 784,712 performance share units (PSUs) under its Omnibus Equity Incentive Plan to selected executives and employees.

The RSUs will vest over one to three years from the grant date, while PSUs will vest after three years subject to meeting specific performance targets. Upon vesting, both RSUs and PSUs can be converted into common shares or, at the Board's discretion, settled in cash.

Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) has announced the promotion of Melanie Ramsey from Chief Commercial Officer to Chief Operating Officer, effective January 1, 2025. Ramsey, who joined the company in 2018, has been important in developing premium brands and product innovation, while aligning commercial strategies with operational excellence.

In her new role as COO, Ramsey will oversee daily operations and execute strategic growth initiatives. With over 25 years of global experience, including senior leadership positions at Diageo and Beiersdorf, she brings extensive expertise in commercial and operational functions. CEO Margaret Brodie highlighted Ramsey's six-year track record of commitment and leadership in driving the company's commercial and operational success.

Rubicon Organics has secured C$10,000,000 in credit facilities from Community Savings Credit Union and another lender. The facilities have a five-year term with a ten-year amortization period and carry a 6.75% annual interest rate. The credit is secured by first-ranking security interests in the company's present and after-acquired personal property. The funds will be used to repay a US$8,000,000 secured debenture owed to Green Island Investments , which matures on December 31, 2024.